These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7413661)

  • 1. Studies of biologic properties of a polysulfated chondroitin, A73025.
    Radhakrishnamurthy B; Godofsky A; Dalferes ER; Srinivasan S; Vijayagopal P; Berenson G
    Proc Soc Exp Biol Med; 1980 Sep; 164(4):410-4. PubMed ID: 7413661
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of polysulfated glycosaminoglycans obtained from bovine lung tissue on hypercholesterolemic rabbits.
    Nakashima Y; Tasaki H; Yashiro A; Kawashima T; Kuroiwa A; Koide O
    Artery; 1990; 17(5):248-70. PubMed ID: 2396900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of chemical and biologic properties of a fraction of sulodexide, a heparin-like glycosaminoglycan.
    Radhakrishnamurthy B; Sharma C; Bhandaru RR; Berenson GS; Stanzani L; Mastacchi R
    Atherosclerosis; 1986 May; 60(2):141-9. PubMed ID: 3087374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic actions of heparin.
    Rosenberg RD
    Semin Hematol; 1977 Oct; 14(4):427-40. PubMed ID: 144323
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heparin in therapeutics (author's transl)].
    Capel P
    Rev Med Brux; 1981 Mar; 2(3):181-9. PubMed ID: 7015442
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
    Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of glycosaminoglycan composition and biologic activity of Vessel, a hypolipidemic agent.
    Radhakrishnamurthy B; Ruiz HA; Srinivasan SR; Preau W; Dalferes ER; Berenson GS
    Atherosclerosis; 1978 Oct; 31(2):217-29. PubMed ID: 728239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
    Williams EC; Huppert BJ; Asakura S
    J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of antithrombin III activity by carrageenans.
    Kindness G; Long WF; Williamson FB
    Thromb Res; 1979; 15(1-2):49-60. PubMed ID: 483282
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.
    Nurmohamed MT; Fareed J; Hoppensteadt D; Walenga JM; ten Cate JW
    Semin Thromb Hemost; 1991; 17 Suppl 2():205-13. PubMed ID: 1948091
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia.
    Keeling DM; Richards EM; Baglin TP
    Br J Haematol; 1994 Feb; 86(2):425-6. PubMed ID: 7515270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heparin sulfate fractions on coagulation and hemostasis.
    Nader HB; Dietrich CP
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):504-8. PubMed ID: 4275736
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycosaminoglycans and the control of cell surface proteinase activity.
    Long WF; Williamson FB
    Med Hypotheses; 1983 Jul; 11(3):285-308. PubMed ID: 6358810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of heparin and a semi-synthetic heparin analogue on platelet aggregation, lipoprotein lipase and other laboratory tests in surgical patients.
    Törngren S; Norén I; Forsskåhl B; Sipilä H
    Thromb Res; 1983 Jun; 30(5):527-34. PubMed ID: 6412390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the mechanism of heparin-induced potentiation of platelet aggregation.
    Yamamoto M; Watanabe K; Ando Y; Iri H; Handa H; Yoshii Y; Imai M; Sugiura K; Ikeda Y
    Thromb Res; 1982 May; 26(3):159-64. PubMed ID: 7112512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulations of thrombin activity by polyelectrolytes in the presence of antithrombin III.
    Schiele J; Heuck CC
    Semin Thromb Hemost; 1991; 17 Suppl 1():35-41. PubMed ID: 2068569
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of lipoprotein lipase with lipid lowering effect in man by intravenous injection of an extractive mucopolysaccaride complex (EMC).
    Rubba P; Rivellese A; Griffo S; Mancini M
    Pharmacol Res Commun; 1977 Jul; 9(7):675-8. PubMed ID: 142992
    [No Abstract]   [Full Text] [Related]  

  • 18. Absorption by the rat intestinal tract of fluorescein-labelled pig duodenal glycosaminoglycans.
    Pescador R; Diamantini G; Mantovani M; Malandrino S; Riva A; Casu B; Oreste P
    Arzneimittelforschung; 1980; 30(11):1893-6. PubMed ID: 7192999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic implications of heparin interactions with other drugs.
    Colburn WA
    Drug Metab Rev; 1976; 5(2):281-93. PubMed ID: 802469
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparinoid activities of depolymerized chondroitin polysulfates.
    Nagasawa K; Ogamo A; Hayashi S
    Arch Biochem Biophys; 1972 Jun; 150(2):451-8. PubMed ID: 5044036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.